Results 101 to 110 of about 29,772 (222)

Risk factors for visceral leishmaniasis in India: further evidence on the role of domestic animals.

open access: yes, 2010
OBJECTIVE: Studies investigating risk factors for visceral leishmaniasis (VL) on the Indian Subcontinent have shown contradictory results related to the role of domestic animals. In some studies having animals in or around the house was a risk factor, in
Singh, SP   +15 more
core   +1 more source

Visceral leishmaniasis in eastern Africa--current status. [PDF]

open access: yes, 2007
Visceral leishmaniasis (VL) is among the most neglected of the tropical diseases, afflicting the poorest of the poor. In eastern Africa, VL causes at least 4000 deaths annually, a loss of approximately 385,000 disability-adjusted life years.
Reithinger, Richard   +3 more
core   +1 more source

Dermatologic Manifestations in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis

open access: yesActa Medica Iranica, 2019
The human T cell lymphotropic virus type-1 (HTLV-1) is associated with adult T cell leukemia/lymphoma (ATL) and other disorders, including a slowly progressive demyelinating paraparesis, known as HTLV-1-associated myelopathy/tropical spastic paraparesis (
Reza Boostani   +8 more
doaj  

Evaluation of first generation vaccines against human leishmaniasis and the implication of Leishmanin Skin Test (LST) response in disease prevalence [PDF]

open access: yes, 2011
This study reports the detailed analysis of the data from ten different clinical trials of first generation prophylactic vaccines (FGV) against leishmaniasis.
Noazin, Sassan
core   +1 more source

Presentation of AIDS with Disseminated Cutaneous and Visceral Leishmaniasis in Iran

open access: yesCase Reports in Infectious Diseases, 2015
Leishmaniasis is an infectious disease in form of visceral (VL), cutaneous (CL), and mucocutaneous (MCL) leishmaniasis. Immunocompromised patients have increased risk of Leishmania infection, especially in endemic areas for visceral leishmaniasis, where
Mohammadali Davarpanah   +2 more
doaj   +1 more source

Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial. [PDF]

open access: yes, 2010
OBJECTIVE: To test the effectiveness of large scale distribution of longlasting nets treated with insecticide in reducing the incidence of visceral leishmaniasis in India and Nepal.
Chappuis, F.   +61 more
core   +1 more source

Clinical features and diagnosis of 42 travellers with cutaneous leishmaniasis.

open access: yes, 2006
BACKGROUND: Leishmania species that occur within different geographical areas may cause different clinical manifestations, virulence and drug sensitivity. Patients/Methods.
Lockwood, D   +7 more
core   +1 more source

Clinical pattern and treatment outcome of cutaneous leishmaniasis patients in Somali region, eastern Ethiopia

open access: yesSkin Health and Disease
Background Neglected tropical diseases, affecting over a billion people, include leishmaniasis, a protozoan parasite found in over 20 species. It is classified into three types: visceral, cutaneous, and muco‐cutaneous leishmaniasis, with cutaneous ...
Abdilahi Ibrahim Muse   +2 more
doaj   +1 more source

Symmetrical Cutaneous Leishmaniasis

open access: yesActa Dermato-Venereologica, 2005
Sir, Cutaneous leishmaniasis (CL) is a protozoan disease present in Old and New Worlds (1, 2). It is endemic in the Mediterranian basin, particularly in the rural areas of Sicily where almost 60% of Italian cases occur. The disease is caused by parasites of the genus Leishmania infantum, carried by specific species of sandflies as Phlebotomus ...
GUARNERI, Claudio   +1 more
openaire   +2 more sources

Leishmania isoenzyme polymorphisms in Ecuador: Relationships with geographic distribution and clinical presentation

open access: yes, 2006
Background: Determinants of the clinical presentation of the leishmaniases are poorly understood but Leishmania species and strain differences are important.
Cooper Philip J   +48 more
core   +1 more source

Home - About - Disclaimer - Privacy